CD274 and non-small cell lung carcinoma: Kaplan-Meier analysis was used to evaluate associations between PD-L1 marker status for IHC and RNA-seq with median progression-free survival (PFS) and overall survival (OS) for pembrolizumab-treated NSCLC patients in the validation cohort.